LivaNova
Manufacturing · United Kingdom · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
20 Eastbourne Ter, London, Greater Londo...Phone Number
+44 2033250660Website
www.livanova.comRevenue
$1.4 BillionStock Symbol
LIVNIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
6
8
1
1
1
1
About LivaNova
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales represeRead more
LivaNova Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is LivaNova your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if LivaNova is spiking on competitors!
Funding: Get notified immidiatlly once LivaNova has new funding data
Click to see if LivaNova had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on LivaNova recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at LivaNova
Product Launch: Get notified when LivaNova launches new products
LivaNova, which may be a good buyer, showed buying intent in Masked Content Topic
Check if LivaNova has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at LivaNova
Find 3 more new buyers
Compare Similar Companies to LivaNova
Compare insights from companies similar to LivaNova, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$408.5M
1K - 5K
Private
$921.8M
2006
SR
Shana RossSenior Vice President and Chief Human Resources Officer
Company Profile Activity
Activity Insights
LivaNova is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
LivaNova is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about LivaNova.
LivaNova Tech Stack
A closer look at the technologies used by LivaNova
Most Recent Scoops
Person-Based
Pharmaceuticals
Open Position
Person-Based
Events, Corporate Strategy
Person-Based
Events
Person-Based
Events
LivaNova News & Media
LivaNova PLC (LIVN) Q1 2026 Earnings Call Transcript
LivaNova PLC (LIVN) Q1 2026 Earnings Call May 6, 2026 8:00 AM EDTCompany ParticipantsBriana Gotlin - Vice President of Investor RelationsVladimir Makatsaria...LivaNova (LIVN) beats quarterly expectations but shares slip on cautious guidance reaction
LivaNova (NASDAQ:LIVN) reported first-quarter results on Wednesday that came in ahead of Wall Street expectations, although shares fell more than 2% in premarket trading as investors weighed the company’s updated guidance against analyst forecasts. The medical technology group posted adjusted earnings per share of $0.LivaNova (LIVN) Announces FDA Approval of aura6000 System for Obstructive Sleep Apnea
LivaNova PLC (NASDAQ:LIVN) is one of the 12 Best UK Stocks to Buy According to Hedge Funds. On March 19, 2026, LivaNova PLC (NASDAQ:LIVN) announced that the FDA granted premarket approval for its aura6000 System for treating adults with moderate to severe obstructive sleep apnea. The system uses proximal hypoglossal nerve stimulation to address patients […]LivaNova eyes 2027 launch of neural sleep apnoea therapy after FDA approval
LivaNova's aura6000 system delivers synchronised electrical pulses to the hypoglossal nerve to prevent airways collapse in OSA patients during sleep.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding LivaNova
Sign Up For FreeTo access detailed company insights
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,... Read More
